Business Context and Reporting Period
This Form 8-K Current Report was filed by Myomo, Inc. (NYSE American: MYO) on April 28, 2021, covering events occurring on April 22, 2021. The filing details the execution of renewed executive employment agreements for the company's top leadership team.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation terms.
Material Changes and Executive Compensation
On April 22, 2021, Myomo, Inc. entered into renewed employment agreements with three key executives. The agreements establish base salaries, bonus targets, and severance provisions effective immediately, with salary increases scheduled for July 1, 2021.
- Paul R. Gudonis (CEO, President, Chairman):
- Base Salary: $240,000 (increasing to $247,200 on July 1, 2021).
- Annual Bonus: Up to 75% of base salary based on strategic and financial goals.
- Term: Three years expiring December 31, 2023.
- Severance (Without Cause): 12 months of base salary plus bonus, 12 months of health contributions, and accelerated vesting of stock options for 12 months.
- Change in Control: Immediate full acceleration of all stock options if terminated without cause within 12 months of a change in control.
- David A. Henry (CFO):
- Base Salary: $215,000 (increasing to $221,500 on July 1, 2021).
- Annual Bonus: Up to 75% of base salary.
- Term: Two-year initial term with automatic one-year renewal.
- Severance (Without Cause): 75% of base salary plus bonus, 9 months of health contributions, and accelerated vesting for 6 months.
- Change in Control: 100% of base salary plus bonus, 12 months of health contributions, and immediate full acceleration of stock options.
- Micah J. Mitchell (Chief Commercial Officer):
- Base Salary: $180,000 (increasing to $185,400 on July 1, 2021).
- Annual Bonus: Up to 80% of base salary.
- Term: Two-year initial term with automatic one-year renewal.
- Severance (Without Cause): 50% of base salary plus bonus, 6 months of health contributions, and accelerated vesting for 6 months.
- Change in Control: 75% of base salary plus bonus, 6 months of health contributions, and immediate full acceleration of stock options.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary regarding business operations. The primary risk disclosed relates to the potential financial liability associated with executive severance packages, particularly in the event of a change in control or termination without cause.
Investor Verification Checklist
- Verify the total annualized compensation cost for the executive team including the scheduled July 2021 salary increases.
- Review the full text of Exhibits 10.1, 10.2, and 10.3 for specific definitions of "Change in Control" and performance metrics for bonuses.
- Assess the impact of potential severance payouts on the company's cash position, given the company's status as an emerging growth company.
- Confirm the vesting schedules of existing stock options held by these executives to understand the dilution impact of accelerated vesting clauses.